@article{7e547fba174846f7b93ffeb268d7e992,
title = "Impact of dupilumab on SNOT-22 sleep and function scores in CRSwNP",
author = "Busse, {William W.} and Andrew Wellman and Zuzana Diamant and Cohen, {Noam A.} and Chaker, {Adam M.} and Claus Bachert and Shahid Siddiqui and Haixin Zhang and Scott Nash and Khan, {Asif H.} and Jacob-Nara, {Juby A.} and Rowe, {Paul J.} and Yamo Deniz",
note = "Funding Information: This research was sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. Medical writing/editorial assistance provided by Stephen Whiting, PhD, of Adelphi Group, was funded by Sanofi and Regeneron Pharmaceuticals, Inc. Funding Information: This research was sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. Medical writing/editorial assistance provided by Stephen Whiting, PhD, of Adelphi Group, was funded by Sanofi and Regeneron Pharmaceuticals, Inc. Conflicts of interest: W. W. Busse reports consultancy from Regeneron Pharmaceuticals, Inc., Sanofi. A. Wellman reports consultancy from Apnimed, Inc., Inspire, Nox, Somnifix; has received grants from Sanofi and Somnifix; and has financial interest in Apnimed, Inc. Z. Diamant acted as Research Director at QPS-NL, an institution which has received research support from several bio-pharmaceutical companies in the past 3 years. Furthermore, Z. Diamant has received honoraria or speaker fees serving on advisory boards or as a consultant from ALK, Antabio, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, HAL Allergy, Merck Sharp & Dohme, and Sanofi-Regeneron, all outside the submitted work. N. A. Cohen reports advisory board fees from Novartis Pharmaceuticals, Oyster Point Pharmaceuticals, Regeneron Pharmaceuticals, Inc., and Sanofi, and licensing agreement from GeneOne Life Sciences. A. M. Chaker reports support and clinical studies grants and/or advisory board fees and speaker fees from Abello, Allergopharma, ALK, AstraZeneca, ASIT Biotech, Bencard/Allergen Therapeutics, Immunotek, LETI, Lofarma, GlaxoSmithKline, Novartis, Roche, Sanofi, Regeneron Pharmaceuticals Inc., Zeller, the German Federal Ministry of Education and Research, and from the European Institute of Technology (EIT Health). C. Bachert reports advisory board fees and speakers{\textquoteright} fees from ALK, AstraZeneca, GlaxoSmithKline, Mylan, Novartis, Sanofi, and Stallergenes Greer. S. Siddiqui, H. Zhang, S. Nash, and Y. Deniz are employees and may hold stock and/or stock options in Regeneron Pharmaceuticals, Inc. A. H. Khan, J. A. Jacob-Nara, and P. J. Rowe are employees and may hold stock and/or stock options in Sanofi.",
year = "2022",
month = sep,
doi = "10.1016/j.jaip.2022.05.013",
language = "English",
volume = "10",
pages = "2479--2482.e3",
journal = "Journal of Allergy and Clinical Immunology: In Practice",
issn = "2213-2198",
number = "9",
}